Teva Pharmaceutical reports 5% fall in Q4 2022 revenue
Is Teva Pharmaceutical Industries Ltd (TEVA) Stock a Smart Value?
Teva Pharmaceutical's Sales Slump 18% - WSJ
Teva Pharmaceutical Industries Stock Gives Every Indication Of Being Modestly Undervalued
Analysis: Teva Pharmaceuticals is bogged down by legal issues, fails to kick-start growth | Ctech
Teva Pharmaceutical Industries' new CEO Jeremy Levin speaks during a news conference in Tel Aviv May 9, 2012. Teva Pharmaceutical Industries posted a 40 percent jump in quarterly profit that beat estimates,
US accuses Teva of illegally fixing prices of drugs - Taipei Times
Does Teva Pharmaceutical Deserve a Place in Your 2022 Portfolio?
Teva Pharmaceuticals - Wikipedia
Teva Pharmaceutical Industries. Information about the issuer. (LEI 549300BAFGM4RC74ZJ94, SWIFT TEVPILITXXX). News and credit ratings. Tables with accounting and financial reports.
Teva Pharmaceutical Will Pay Over $4 Billion in Opioid Settlement - Bloomberg